Leprous neuropathy
- PMID: 39051539
- DOI: 10.1097/WCO.0000000000001304
Leprous neuropathy
Abstract
Purpose of review: Leprosy is still an important cause of neuropathy. Late diagnosis is associated with development of severe nerve impairment.
Recent findings: early diagnosis and early treatment is essential in order to avoid disability and disease transmission. Recognizing that leprosy is a neurological disease is a fundamental step to the Leprosy zero action proposed by the World Health Organization.
Summary: leprosy neuropathy manifests as a mononeuropathy or a multiple mononeuropathy with a temperature-dependent distribution. Electromyography, high-resolution sonography serology and PCR help make the diagnosis. Multidrug therapy should be instituted.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Han XY, Seo YH, Sizer KC, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol 2008; 130:856–864.
-
- Lau KHV. Neurological complications of leprosy. Semin Neurol 2019; 39:462–471.
-
- World Health Organization. Global leprosy update, 2022: new paradigm – control to elimination. Wkly Epidemiol Rec 2023; 98:409–430.
-
- World Health Organization. Towards zero leprosy. Global leprosy (Hansen's disease) strategy 2021–2030. New Delhi: WHO Regional Office for South-East Asia; 2021.
-
- Dos Santos DF, Borges IS, Garcia LP, et al. Description of electroneuromiographic and laboratorial findings in leprosy neuropathy, according to its clinical forms: the confirmation of a spectral disease. Front Med (Lausanne) 2024; 10:1304131.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
